CanSAR: Update to the cancer translational research and drug discovery knowledgebase

55Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

canSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments. canSAR is widely used internationally by academia and industry. Here we describe major enhancements to canSAR including new and expanded data. We also describe the first components of canSARblack-an advanced, responsive, multi-device compatible redesign of canSAR with a question-led interface.

Cite

CITATION STYLE

APA

Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C., Di Micco, P., … Al-Lazikani, B. (2019). CanSAR: Update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research, 47(D1), D917–D922. https://doi.org/10.1093/nar/gky1129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free